GASTROINTESTINAL NEUROENDOCRINE TUMORS
Clinical trials for GASTROINTESTINAL NEUROENDOCRINE TUMORS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL NEUROENDOCRINE TUMORS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL NEUROENDOCRINE TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation therapy targets Hard-to-Treat tumors in stomach and adrenal glands
Disease control Recruiting nowThis study tests a new drug that delivers radiation directly to cancer cells in people with advanced gastrointestinal neuroendocrine tumors or pheochromocytoma/paraganglioma that have already been treated with radiation therapy. The drug works by attaching to a protein found on t…
Matched conditions: GASTROINTESTINAL NEUROENDOCRINE TUMORS
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:54 UTC
-
New radiation therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial tests a new drug that delivers radiation directly to cancer cells with a specific protein (somatostatin receptor). It is for adults with advanced lung, kidney, head and neck, digestive tract, or adrenal gland tumors that cannot be removed by surgery. The go…
Matched conditions: GASTROINTESTINAL NEUROENDOCRINE TUMORS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:55 UTC